|
EspAddText
EspRemoveText
|
Health Canada consultation on proposed vaping products promotion regulations
|
Response to consultation
|
2020
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on vaping products labelling and packaging regulations
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on potential market for cannabis health products that would not require practitioner oversight
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on the impact of vaping products advertising on youth and non-users of tobacco products
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Health Canada’s consultation on new health-related labelling for tobacco products
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada
|
Parliamentary submission
|
2016
|
|
EspAddText
EspRemoveText
|
Canadian Medical Association Submission to the House of Commons Study on E-Cigarettes
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Canadian Medical Association Submission to Health Canada's Notice of proposed order to amend the schedule to the Tobacco Act
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Answering the Wake-up Call: CMA’s Public Health Action Plan : CMA submission to the National Advisory Committee on SARS and Public Health
|
Parliamentary submission
|
2010
|